Article
Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society - 1 Feb 2017
Konuma Takaaki, Takahashi Shunsuke, Kiyuna Tomohiko, Miharu Yuta, Suzuki Masato, Shibata Hiroko, Kato Seiko, Takahashi Satoshi, Tojo Arinobu
Abstract excerpt
The prophylactic use of antifungal drugs in allogeneic hematopoietic cell transplant recipients has revealed that the rate of non-albicans candidemia has increased. We herein report the case of a patient with adult T-cell leukemia who developed candidemia due to Candida fermentati during micafungin treatment after cord blood transplantation. The isolate was identified on day 47 by sequencing of the internal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
